Drug and vaccine authorizations for COVID-19: Overview

Drug and vaccine authorizations for COVID-19: Overview Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also review the information that will be provided to health care practitioners and consumers about the product. After the review, we may authorize the drug or vaccine for sale in Canada only if the benefits of the product outweigh the potential risks. 2020-10-02 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19pandemicdrug and vaccine authorizationsauthorize the drug or vaccine for salepotential benefits and risks of a drug or vaccinehealth care practitioners and consumersbenefits of the productpotential risks Drug and vaccine authorizations for COVID-19: OverviewHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization.html Drug and vaccine authorizations for COVID-19: OverviewHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/autorisations.html

Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also review the information that will be provided to health care practitioners and consumers about the product. After the review, we may authorize the drug or vaccine for sale in Canada only if the benefits of the product outweigh the potential risks.

Data and Resources

Similar records